Motilal Oswal reiterated a "Buy" rating for Biocon with a price target of Rs520. The target has been revised but positive view on the stock remains intact.

Axis Securities has reiterated its BUY recommendation on Biocon Ltd, setting a revised target price of Rs 435, even as the company reported a mixe

Axis Securities Limited has issued a BUY recommendation for Biocon Limited, positioning the pharmaceutical giant as their "Pick of the Week" with a compelling investment thesis.

India’s biotechnology industry, one of the fastest-expanding sectors globally, is blazing new trails across healthcare, pharmaceuticals, and sustainability.

Biocon share price jumped 2.53 percent in today's session. The stock is trading close to yearly highs and is looking bullish on technical charts.

Biocon Share price was trading 2.7 percent higher today and the stock is looking bullish on technical charts. Biocon could also see a fresh 52-week high in the coming sessions.